A truncated isoform of the PP2A B56gamma regulatory subunit reduces irradiation-induced Mdm2 phosphorylation and could contribute to metastatic melanoma cell radioresistance.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Histology and Histopathology

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.14670/HH-19.391PMID 15024700
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A truncated isoform of the protein phosphatase 2A B56gamma regulatory subunit may promote genetic instability and cause tumor progression.

  2003cited by this paper
• Cyclin G recruits PP2A to dephosphorylate Mdm2.

  2002cited by this paper
• Structure, Expression and Chromosome Mapping of MLZE, a Novel Gene Which Is Preferentially Expressed in Metastatic Melanoma Cells

  2001cited by this paper
• ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.

  2001cited by this paper
• The protein phosphatase 2A subunit Bγ gene is identified to be differentially expressed in malignant melanomas by subtractive suppression hybridization

  2001cited by this paper
• Increased expression of a nucleolar Nop5/Sik family member in metastatic melanoma cells: evidence for its role in nucleolar sizing and function.

  2001cited by this paper
• Cyclin A-CDK Phosphorylation Regulates MDM2 Protein Interactions*

  2001cited by this paper
• A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation

  2000cited by this paper
• Protein phosphatase 2A: a panoply of enzymes.

  2000cited by this paper
• Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.

  2000cited by this paper
• A role for heterologous gap junctions between melanoma and endothelial cells in metastasis.

  2000cited by this paper
• Annexin VII as a Novel Marker for Invasive Phenotype of Malignant Melanoma

  2000cited by this paper
• v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation.

  2000cited by this paper
• Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage.

  1999cited by this paper
• A new member of the GTPase superfamily that is upregulated in highly metastatic cells.

  1999cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint

  1997cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• p53 gene aberrations in non-small-cell lung carcinomas from a smoking population.

  1997cited by this paper
• Involvement of transcription factor encoded by the mouse mi locus (MITF) in apoptosis of cultured mast cells induced by removal of interleukin-3.

  1997cited by this paper
• Structure, expression, and chromosomal localization of human GAK.

  1997cited by this paper
• Repression of p53-mediated transcription by MDM2: a dual mechanism.

  1997cited by this paper
• Malignant melanoma: the role of radiation therapy revisited.

  1996cited by this paper
• Radiation therapy for malignant melanoma.

  1996cited by this paper
• Cyclin G is a transcriptional target of the p53 tumor suppressor protein.

  1994cited by this paper
• Absence of p53 gene mutations in cutaneous melanoma.

  1994cited by this paper
• p53 status and the efficacy of cancer therapy in vivo.

  1994cited by this paper
• Apoptosis in cancer therapy: crossing the threshold.

  1994cited by this paper
• Mutation and expression of the p53 gene in human malignant melanoma

  1994cited by this paper
• Analysis of p53 in human cutaneous melanoma cell lines.

  1994cited by this paper
• p53 is required for radiation-induced apoptosis in mouse thymocytes

  1993cited by this paper
• Thymocyte apoptosis induced by p53-dependent and independent pathways

  1993cited by this paper
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

  1993cited by this paper
• Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

  1993cited by this paper
• Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

  1992cited by this paper
• Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library.

  1992cited by this paper
• Radiation sensitivity in vitro of primary tumors and metastatic lesions of malignant melanoma.

  1992cited by this paper
• Mutational analysis of the human p53 gene in malignant melanoma.

  1991cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

  1990cited by this paper
• Okadaic acid, a potent inhibitor of type 1 and type 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis‐like state in BHK21 cells.

  1990cited by this paper
• Relationship of spontaneous regional lymph node metastases to dose of local irradiation of primary B16 melanomas.

  1989cited by this paper
• Three distinct forms of type 2A protein phosphatase in human erythrocyte cytosol.

  1988cited by this paper
• In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties.

  1980cited by this paper
• The selection and characterization of an invasive variant of the B16 melanoma.

  1979cited by this paper

• Topological features of integrin adhesion complexes revealed by multiplexed proximity biotinylation

  2020cites this paper
• PP2A and tumor radiotherapy

  2020cites this paper
• PP2A-B′ holoenzyme substrate recognition, regulation and role in cytokinesis

  2017cites this paper
• Design, synthesis and biochemical characterization of Fingolimod analogs for targeting PP2A

  2016cites this paper
• Characterization of the interactions between Caspase-9 and phosphatases PP1A and PP2A in apoptosis: applications as therapeutic target in cancer

  2015cites this paper
• Regulation of dynamin-related protein 1-mediated mitochondrial fission by reversible phosphorylation and its contribution to neuronal survival following injury

  2014cites this paper
• Dynamic Regulation of Extracellular Signal-Regulated Kinase (ERK) by Protein Phosphatase 2A Regulatory Subunit B56γ1 in Nuclei Induces Cell Migration

  2013cites this paper
• The role and therapeutic potential of Ser/Thr phosphatase PP2A in apoptotic signalling networks in human cancer cells.

  2012cites this paper
• Regulation and Function of Protein Kinases and Phosphatases

  2011cites this paper
• Determinants for Substrate Specificity of Protein Phosphatase 2A

  2011cites this paper
• Melanoma Cell Signalling: Looking Beyond RAS-RAF-MEK

  2011cites this paper
• Protein phosphatase 2A cooperates with the autophagy-related kinase UNC-51 to regulate axon guidance in Caenorhabditis elegans

  2010cites this paper
• Regulation of the tumour suppressor PP2A by oncogenic tyrosine kinases

  2010cites this paper
• Expression of a soluble isoform of cell adhesion molecule 1 in the brain and its involvement in directional neurite outgrowth.

  2009cites this paper
• Regulation of tyrosine hydroxylase by protein phosphatase 2A

  2008cites this paper
• A tumor suppressor role for PP2A-B56α through negative regulation of c-Myc and other key oncoproteins

  2008cites this paper
• Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme

  2007cites this paper
• Structure of the protein phosphatase 2A holoenzyme.

  2006cites this paper
• Regulation of Class II β-Tubulin Expression by Tumor Suppressor p53 Protein in Mouse Melanoma Cells in Response to Vinca Alkaloid

  2006cites this paper
• Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins.

  2006cites this paper
• PP2A: the expected tumor suppressor.

  2005cites this paper
• Migration and retraction of endothelial and epithelial cells require PHI-1, a specific protein-phosphatase-1 inhibitor protein

  2004cites this paper